Luc Mortelmans

7.1k total citations
129 papers, 4.3k citations indexed

About

Luc Mortelmans is a scholar working on Radiology, Nuclear Medicine and Imaging, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Luc Mortelmans has authored 129 papers receiving a total of 4.3k indexed citations (citations by other indexed papers that have themselves been cited), including 69 papers in Radiology, Nuclear Medicine and Imaging, 27 papers in Pulmonary and Respiratory Medicine and 20 papers in Molecular Biology. Recurrent topics in Luc Mortelmans's work include Medical Imaging Techniques and Applications (41 papers), Cardiac Imaging and Diagnostics (21 papers) and Radiopharmaceutical Chemistry and Applications (17 papers). Luc Mortelmans is often cited by papers focused on Medical Imaging Techniques and Applications (41 papers), Cardiac Imaging and Diagnostics (21 papers) and Radiopharmaceutical Chemistry and Applications (17 papers). Luc Mortelmans collaborates with scholars based in Belgium, Netherlands and Germany. Luc Mortelmans's co-authors include Sigrid Stroobants, Guy Bormans, Johan Nuyts, Patrick Dupont, Alfons Verbruggen, Johan Vansteenkiste, Alex Maes, Frans Van de Werf, Paul R. De Leyn and Patrick Flamen and has published in prestigious journals such as Circulation, Journal of Clinical Oncology and Blood.

In The Last Decade

Luc Mortelmans

123 papers receiving 4.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Luc Mortelmans Belgium 37 2.0k 1.0k 831 658 540 129 4.3k
François Brunotte France 30 1.7k 0.9× 883 0.8× 446 0.5× 996 1.5× 282 0.5× 154 3.7k
Robert Dudczak Austria 40 1.3k 0.7× 650 0.6× 1.1k 1.4× 342 0.5× 718 1.3× 209 5.0k
K Torizuka Japan 39 1.9k 1.0× 743 0.7× 794 1.0× 441 0.7× 333 0.6× 316 4.9k
Norihisa Tonami Japan 34 2.0k 1.0× 892 0.9× 774 0.9× 636 1.0× 392 0.7× 309 4.2k
Anna M. Bennet Sweden 22 1.3k 0.7× 1.0k 1.0× 930 1.1× 1.6k 2.4× 391 0.7× 39 5.5k
Kazuo Kubota Japan 40 1.6k 0.8× 1.4k 1.3× 731 0.9× 302 0.5× 439 0.8× 186 4.5k
Yuji Kuge Japan 40 2.2k 1.1× 1.1k 1.1× 667 0.8× 511 0.8× 482 0.9× 259 5.6k
Michael C. Kreißl Germany 33 933 0.5× 591 0.6× 807 1.0× 425 0.6× 624 1.2× 151 3.8k
Byung‐Tae Kim South Korea 40 2.5k 1.3× 2.0k 1.9× 1.1k 1.3× 332 0.5× 463 0.9× 202 5.2k
Michael L. Goris United States 39 2.3k 1.2× 935 0.9× 614 0.7× 899 1.4× 201 0.4× 134 4.4k

Countries citing papers authored by Luc Mortelmans

Since Specialization
Citations

This map shows the geographic impact of Luc Mortelmans's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luc Mortelmans with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luc Mortelmans more than expected).

Fields of papers citing papers by Luc Mortelmans

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Luc Mortelmans. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luc Mortelmans. The network helps show where Luc Mortelmans may publish in the future.

Co-authorship network of co-authors of Luc Mortelmans

This figure shows the co-authorship network connecting the top 25 collaborators of Luc Mortelmans. A scholar is included among the top collaborators of Luc Mortelmans based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Luc Mortelmans. Luc Mortelmans is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Brepoels, Lieselot, Sigrid Stroobants, Walter De Wever, et al.. (2008). Positron emission tomography in mantle cell lymphoma. Leukemia & lymphoma. 49(9). 1693–1701. 39 indexed citations
2.
Deroose, Christophe M., Satish K. Chitneni, Rik Gijsbers, et al.. (2007). In vitro evaluation of a novel radiolabeled bi-cyclic nucleoside analog as PET reporter probe for Varicella zoster virus thymidine kinase gene expression.
3.
Janssens, Stefan, Jan Bogaert, Koen Theunissen, et al.. (2005). Transplantation of autologous bone marrow-derived stem cells in patients with ST-segment elevation myocardial infarction. Circulation. 112(17).
4.
Vandenberghe, Rik, Mathieu Vandenbulcke, Patrick Dupont, et al.. (2004). Voxel-based parametric mapping of acetylcholinesterase activity using [C-11]PMP positron emission tomography in mild cognitive impairment. Annals of Neurology. 56. 1 indexed citations
5.
Weidemann, Frank, Xiaoshun Liu, Yanming Huang, et al.. (2002). Dobutamine stress echo may not always accurately predict segment viability in chronic global IV ischemia: an experimental study. Journal of the American College of Cardiology. 39. 379–379. 1 indexed citations
6.
Mesotten, Liesbet, Xuesong Liu, Johan Nuyts, et al.. (2001). Transition from chronic stunning to hibernation and further on to necrosis in a porcine model of chronic ischemia identified with PET. Circulation. 104(17). 455–455. 1 indexed citations
7.
Ziętkiewicz, Mirosław, Bartłomiej Perek, Alex Maes, et al.. (1999). Reversed mismatch preceeds match patterns using PET analysis in failing myocardium with patchy necrosis. Circulation. 100(18). 88–88. 4 indexed citations
8.
Stas, Marguerite, Sigrid Stroobants, Patrick Dupont, et al.. (1999). Clinical relevance of whole body FDG-PET (WB-PET) in recurrent malignant melanoma. European Journal of Nuclear Medicine and Molecular Imaging. 26(9). 968–968. 1 indexed citations
9.
Vansteenkiste, Johan, Sigrid Stroobants, Paul De Leyn, et al.. (1998). Role of 18F-2-deoxyglucose positron emission tomography (FDG-PET) after induction chemotherapy In stage IIIA-N2 non-small cell lung cancer (N2-NSCLC). Annals of Oncology. 9. 88–88. 3 indexed citations
10.
Vansteenkiste, Johan, Sigrid Stroobants, Paul De Leyn, et al.. (1997). Lymph node mapping in non-small cell lung cancer with FDG-PET scan: a prospective study in 690 LN levels from 68 patients. 3 indexed citations
11.
Cornette, Luc, Patrick Dupont, Guy Bormans, et al.. (1997). Occipito-temporal pathway involvement in direction discrimination: A PET study. Acta Neurologica Belgica. 97(1). 59–59. 1 indexed citations
12.
Spiessens, Bart, et al.. (1996). Presence of at least one PET mismatch region is necessary for functional benefit after coronary artery bypass surgery. Circulation. 94(8). 1194–1194. 5 indexed citations
13.
Shivalkar, Bharati, Michael A. Borger, Alex Maes, Luc Mortelmans, & Willem Flameng. (1994). Low regional function-associated with high metabolism predicts functional recovery after coronary-bypass surgery. Circulation. 90(4). 251–251. 7 indexed citations
14.
Maes, Alex, Luc Mortelmans, Johan Nuyts, et al.. (1993). Myocardial tissue perfusion measured with PET after successful thrombolysis in patients with acute myocardial infarction. European Heart Journal. 14. 438–438. 1 indexed citations
15.
Bormans, Guy, et al.. (1992). A zn-62/cu-62 generator for the routine production of cu-62-ptsm. Applied Radiation and Isotopes. 43(12). 1437–1441. 12 indexed citations
16.
Mortelmans, Luc, et al.. (1992). Planar vs tomographic quantitation of perfusion defects after thrombolytic therapy. European Journal of Nuclear Medicine and Molecular Imaging. 19(8). 667–667. 2 indexed citations
18.
Mortelmans, Luc, et al.. (1991). Longterm follow-up of the beneficial effect of thrombolysis on global and region al left ventricular function. European Journal of Nuclear Medicine and Molecular Imaging. 18. 653–653.
19.
Mortelmans, Luc, et al.. (1991). Evaluation of myocardial viability by comparison of FDG and MIBI polar maps. European Journal of Nuclear Medicine and Molecular Imaging. 18. 521–521. 1 indexed citations
20.
Appel, B., et al.. (1986). Clinical evaluation of the first 365 patients studied with a 0.15 tesla resistive MRI system.. PubMed. 86(1). 5–10. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026